Nutrigenomics, Methylation, and Organic Acids: Where the Pathways Cross

  • The Great Plains Laboratory, Inc. 11813 West 77th Street Lenexa, KS, 66214 United States

William Shaw, Ph.D. and The Great Plains Laboratory, Inc. are pleased to present "Nutrigenomics, Methylation, and Organic Acids: Where the Pathways Cross" by Matthew Pratt-Hyatt, Ph.D. on Wednesday, November 30. 

Improved technology has brought the realization of personalized medicine closer to a reality. The goal of personalized medicine is to have custom designed treatment plans for each patient. Two of the most important tools to make this new frontier of medicine functional are the Organic Acids Test (which is a metabolic assessment of overall health) and genetic screening, GPL-SNP1000. These two tests work in tandem to help practitioners understand what is happening in the patient’s body by assessing the results of the Organic Acids Test (OAT), and then using the genetic test to determine the best course of treatment. 

This webinar will review some of the major pathways for which markers from both the Organic Acids Test and genetic test are incredibly useful to assess in tandem, such as methylation, neurotransmitter biosynthesis and metabolism, detoxification, and oxalate metabolism. Dr. Pratt-Hyatt will give several examples of how the findings in the OAT, combined with the results for specific genetic SNPs (mutations) can help create optimal courses of treatment. 

CLICK HERE TO SIGN UP